Lite Strategy, Inc. Professional Fees
Lite Strategy, Inc. (LITS) reported Professional Fees of $409.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-05-13
- Lite Strategy, Inc. professional fees for the quarter ending 2026-03-31 was $409.00K, a 33.22% increase year-over-year.
- Lite Strategy, Inc. professional fees for the quarter ending 2025-12-31 was $728.00K, a 145.12% increase year-over-year.
- Lite Strategy, Inc. professional fees for the quarter ending 2025-03-31 was $307.00K.
- Lite Strategy, Inc. professional fees for the quarter ending 2024-12-31 was $297.00K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month |
|---|---|---|---|
| 2026-03-31 | $409.00K 10-Q · filed 2026-05-13 | $1.14M derived: sum of 2 quarters · filed 2026-05-13 | $1.91M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $728.00K 10-Q · filed 2026-02-17 | $1.50M 10-Q · filed 2026-02-17 | |
| 2025-03-31 | $307.00K 10-Q · filed 2026-05-13 | $604.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.22M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $297.00K 10-Q · filed 2026-02-17 | $911.00K 10-Q · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |